Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 451

    1.

    Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion.

    Kreutzer TC, Alge CS, Wolf AH, Kook D, Burger J, Strauss R, Kunze C, Haritoglou C, Kampik A, Priglinger S.

    Br J Ophthalmol. 2008 Mar;92(3):351-5. Epub 2008 Jan 22.PMID: 18211925 [PubMed - indexed for MEDLINE]Related articles

    2.

    Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial.

    Priglinger SG, Wolf AH, Kreutzer TC, Kook D, Hofer A, Strauss RW, Alge CS, Kunze C, Haritoglou C, Kampik A.

    Retina. 2007 Oct;27(8):1004-12.PMID: 18040236 [PubMed - indexed for MEDLINE]Related articles

    3.

    Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.

    Kook D, Wolf A, Kreutzer T, Neubauer A, Strauss R, Ulbig M, Kampik A, Haritoglou C.

    Retina. 2008 Oct;28(8):1053-60.PMID: 18779710 [PubMed - indexed for MEDLINE]Related articles

    4.

    Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.

    Haritoglou C, Kook D, Neubauer A, Wolf A, Priglinger S, Strauss R, Gandorfer A, Ulbig M, Kampik A.

    Retina. 2006 Nov-Dec;26(9):999-1005.PMID: 17151486 [PubMed - indexed for MEDLINE]Related articles

    5.

    Comparison of two doses of intravitreal bevacizumab (Avastin) for treatment of macular edema secondary to branch retinal vein occlusion: results from the Pan-American Collaborative Retina Study Group at 6 months of follow-up.

    Wu L, Arevalo JF, Roca JA, Maia M, Berrocal MH, Rodriguez FJ, Evans T, Costa RA, Cardillo J; Pan-American Collaborative Retina Study Group (PACORES).

    Retina. 2008 Feb;28(2):212-9.PMID: 18301025 [PubMed - indexed for MEDLINE]Related articles

    6.

    Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study.

    Kriechbaum K, Michels S, Prager F, Georgopoulos M, Funk M, Geitzenauer W, Schmidt-Erfurth U.

    Br J Ophthalmol. 2008 Apr;92(4):518-22. Epub 2008 Jan 22.PMID: 18211942 [PubMed - indexed for MEDLINE]Related articles

    7.

    Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial.

    Prager F, Michels S, Kriechbaum K, Georgopoulos M, Funk M, Geitzenauer W, Polak K, Schmidt-Erfurth U.

    Br J Ophthalmol. 2009 Apr;93(4):452-6. Epub 2008 Dec 15.PMID: 19074916 [PubMed - indexed for MEDLINE]Related articles

    8.

    Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion.

    Pai SA, Shetty R, Vijayan PB, Venkatasubramaniam G, Yadav NK, Shetty BK, Babu RB, Narayana KM.

    Am J Ophthalmol. 2007 Apr;143(4):601-6. Epub 2007 Feb 15.PMID: 17306753 [PubMed - indexed for MEDLINE]Related articles

    9.

    Early intravitreal bevacizumab for non-ischaemic central retinal vein occlusion.

    Rensch F, Jonas JB, Spandau UH.

    Acta Ophthalmol. 2009 Feb;87(1):77-81. Epub 2008 Oct 17.PMID: 18937800 [PubMed - indexed for MEDLINE]Related articles

    10.

    The effects of intravitreal bevacizumab on patients with macular edema secondary to branch retinal vein occlusion.

    Ahmadi AA, Chuo JY, Banashkevich A, Ma PE, Maberley DA.

    Can J Ophthalmol. 2009 Apr;44(2):154-9.PMID: 19491948 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion.

    Rabena MD, Pieramici DJ, Castellarin AA, Nasir MA, Avery RL.

    Retina. 2007 Apr-May;27(4):419-25.PMID: 17420692 [PubMed - indexed for MEDLINE]Related articles

    12.

    Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion.

    Chung EJ, Hong YT, Lee SC, Kwon OW, Koh HJ.

    Graefes Arch Clin Exp Ophthalmol. 2008 Sep;246(9):1241-7. Epub 2008 Jun 11.PMID: 18546006 [PubMed - indexed for MEDLINE]Related articles

    13.

    Early intravitreal bevacizumab for non-ischaemic branch retinal vein occlusion.

    Rensch F, Jonas JB, Spandau UH.

    Ophthalmologica. 2009;223(2):124-7. Epub 2008 Dec 17.PMID: 19088494 [PubMed - indexed for MEDLINE]Related articles

    14.

    Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study.

    Iturralde D, Spaide RF, Meyerle CB, Klancnik JM, Yannuzzi LA, Fisher YL, Sorenson J, Slakter JS, Freund KB, Cooney M, Fine HF.

    Retina. 2006 Mar;26(3):279-84.PMID: 16508427 [PubMed - indexed for MEDLINE]Related articles

    15.

    Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion.

    Spaide RF, Chang LK, Klancnik JM, Yannuzzi LA, Sorenson J, Slakter JS, Freund KB, Klein R.

    Am J Ophthalmol. 2009 Feb;147(2):298-306. Epub 2008 Oct 17.PMID: 18929354 [PubMed - indexed for MEDLINE]Related articles

    16.

    Treatment of branch retinal vein occlusion induced macular edema with bevacizumab.

    Abegg M, Tappeiner C, Wolf-Schnurrbusch U, Barthelmes D, Wolf S, Fleischhauer J.

    BMC Ophthalmol. 2008 Sep 29;8:18.PMID: 18823536 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study.

    Costa RA, Jorge R, Calucci D, Melo LA Jr, Cardillo JA, Scott IU.

    Retina. 2007 Feb;27(2):141-9.PMID: 17290194 [PubMed - indexed for MEDLINE]Related articles

    18.

    Retinal sensitivity after intravitreal injection of bevacizumab for the treatment of macular edema secondary to retinal vein occlusion.

    Yamaike N, Tsujikawa A, Sakamoto A, Ota M, Kotera Y, Miyamoto K, Kita M, Yoshimura N.

    Retina. 2009 Jun;29(6):757-67.PMID: 19289982 [PubMed - indexed for MEDLINE]Related articles

    19.

    Bevacizumab in retinal vein occlusion-results of a prospective case series.

    Stahl A, Agostini H, Hansen LL, Feltgen N.

    Graefes Arch Clin Exp Ophthalmol. 2007 Oct;245(10):1429-36. Epub 2007 Mar 14.PMID: 17356824 [PubMed - indexed for MEDLINE]Related articles

    20.

    Short-term results of intravitreal bevacizumab for macular edema with retinal vein obstruction and diabetic macular edema.

    Byeon SH, Kwon YA, Oh HS, Kim M, Kwon OW.

    J Ocul Pharmacol Ther. 2007 Aug;23(4):387-94.PMID: 17803438 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data